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Article
Direct correlation of electrochemical
behaviors with anti-thrombogenicity
of semiconducting titanium oxide films
Guojiang Wan1, Bo Lv1, Guoshou Jin1, Manfred F Maitz1,2,
Jianzhang Zhou3 and Nan Huang1
Abstract
Biomaterials-associated thrombosis is dependent critically upon electrochemical response of fibrinogen on material
surface. The relationship between the response and anti-thrombogenicity of biomaterials is not well-established.
Titanium oxide appears to have good anti-thrombogenicity and little is known about its underlying essential chemistry.
We correlate their anti-thrombogenicity directly to electrochemical behaviors in fibrinogen containing buffer solution.
High degree of inherent n-type doping was noted to contribute the impedance preventing charge transfer from fibrino-
gen into film (namely its activation) and consequently reduced degree of anti-thrombogenicity. The impedance was the
result of high donor carrier density as well as negative flat band potential.
Keywords
Anti-thrombogenicity, biomaterials-associated thrombosis, blood compatibility, interfacial charge transfer, electrochem-
ical behavior, titanium oxide film
Introduction
Biomaterials-associated thrombosis is of topical con-
cern in biocompatibility of materials, in particular for
blood-contacting implantable biomaterials.1–4 Almost
all natural and synthetic materials explored so far
tend to induce an extent of thrombogenicity on surface
when in contact with blood. Basically, the foreign sur-
face induces coagulation cascade reactions which usu-
ally start from the activation of coagulating factors.
For instance, the first coagulating factor protein
fibrinogen is absorbed on the surface initially and is
activated, then triggers the cascade and finally termin-
ates with formation of fibrous clots, during which
accompanying interactions with platelets and other
coagulating factors occur. The anti-thrombogenicity
of biomaterials is dependent upon the nature of the
solid surface and more critically upon the interfacial
phenomena between biomaterials and blood, i.e. inter-
actions of proteins and platelets with surfaces.
Extensive efforts have been taken to study the thrombo-
genic behaviors of biomaterials and develop desired
anti-thrombogenic materials.5 Surface modification
with blood compatible film/coating is noted as an
important strategy. Among them, titanium oxide film
appears to be relatively anti-thrombogenic as compared
to even low-temperature-isotropic-pyrolytic-carbon as
the commonly used fabricating material for artificial
heart valve.6,7 Intensive investigations have been car-
ried out to find its good anti-thrombogenicity mainly
due to its unique semiconducting property.7–14
Nevertheless, titanium oxide films out of same tech-
nique do not possess same degree of anti-thrombogeni-
city, even when they seem to have large extent
of similarity in surface characteristics. Underlying
chemistry of interactions between film and
coagulating factors might be decisive in fathoming
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anti-thrombogenicity mechanism, screening and
designing of blood compatible biomaterials.
Activation of fibrinogen on surface is crucial in the
coagulation process.3 One hyposthesis suggests that
such activation is characterised with an electrochemical
interfacial charge tranfer reaction from fibronogen into
solid surface.15–17 The ease of electrochemical charge
transfer seems to be the most important determinant
of thrombogenicity on biomaterials, which is deter-
mined mainly by the electrochemical behavior of the
materials with fibrinogen in blood. Preventing charge
transfer is particularly effective and has been illustrated
for semi-conducting titanium oxide and silicon car-
bide.6,18 Nevertheless, there is rarely experimental cor-
relation between the electrochemical behaviors of such
semi-conducting biomaterials and their anti-
thrombogenicity.19–21
The aim of this work is to ascertain the essential
relationship between electrochemical response of titan-
ium oxide to fibrinogen and its anti-thrombogenic per-
formance. Titanium oxide films with different
stoichiometry were obtained with vacuum deposition
process to have different semiconducting properties.
The prepared titanium oxide films were compared and
analyzed in electrochemical behaviors in fibrinogen
containing phosphate buffer solution as well as their
anti-thrombogenic evaluations of fibrinogen denatural-
ization, platelets adhesion and clotting time. Electronic
structure and energetics of titanium oxide films in con-
tact with blood account for the extent of impedance of
charge transfer from fibrinogen into film is discussed to
directly correlate its anti-thrombogenicity.
Materials and methods
Synthesis of titanium oxide films
High purity (99.995%) titanium disk (12mm diameter
and 2mm thickness) specimens were mechanically
smoothed first by grinding with SiC paper progressively
up to 4000 grits, and then polished with 0.5mm dia-
mond cloth. The specimens were cleaned in ultrasonic
bath with acetone, ethanol and distilled water sequen-
tially before deposition. The titanium oxide films were
synthesized on the pure titanium matrix and silicon
wafer by unbalanced magnetron sputtering (UBMS)
deposition, with titanium as metal arc source to pro-
duce metal plasma. The titanium plasma reacted with
oxygen introduced (mixed with argon for enhanced
excitation plasma) in the vacuum system, and the
oxygen partial pressures were adjusted by flow ratio
of oxygen/argon. The technique details of fabrication
of the films are referred to Kelly and Arnell.22 The Ti-O
films with different stoichiometry of O/Ti ratio were
obtained by controlling the flow of oxygen. The main
instrumental conditions are shown in Table 1.
Characterization
The chemical states of titanium, oxygen and carbon on
near-surface (sputtered by around 5 nm) of the synthe-
sized films were studied by X-ray photoelectron spec-
troscopy (XPS, Model PHI5600, Perkin-Elmer, USA)
using monochromated Mg Ka X-rays operating at
14 kV. The spectra were curve-fitted using a computer-
assisted Gaussian–Lorentzian peak model. The binding
energy of the C 1 s line was taken as 284.6 0.4 eV for
calibrating the obtained spectra. X-ray diffraction
(XRD, X’Pert ProMPD) were employed to characterize
the structure of the films, with a glancing angle of 0.5
within a scanning range from 20 to 80.
Electrochemical impedance spectroscopy
Electrochemical impedance spectroscopy (EIS) offers a
powerful method to analyze electrochemical behavior,
in particular impedance feature of interfacial charge
transfer between solid and solution. EIS measurements
were conducted on an electrochemical workstation
(IM6, Zahner, Germany), with a three-electrode set-
up electrochemical cell. A platinum slice was used as
counter electrode, and a saturated calomel electrode
(SCE) was employed as the reference electrode. The
prepared Ti-O films samples deposited titanium
(Ti-O/Ti) were taken as working electrode which were
epoxy-resin-sealed to expose only researched Ti-O film
surface. Phosphate buffered saline (PBS, pH 7.2,
purchased from Sigma) and fibrinogen (human
plasma fibrinogen purchased from Sigma-Aldrich)-con-
taining PBS (PBSþFbg, 2mg/mL) were used as electro-
lytes. Spectra were obtained at open-circuit potential of
the Ti-O/Ti sample in PBS and PBSþFbg solution,
Table 1. Instrumental conditions of unbalanced magnetron sputtering preparation of Ti-O films.
Samples Bias voltage (V) DC current (A) Distance (mm)
Deposition
time (min)
Ar/O ratio
(SCCM)
Ti-O #1 150 3 80 20 60/14
Ti-O #2 10 60/9
Ti-O #3 8 60/7
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with alternating applied potential of 5mV amplitude,
scanning from 10 kHz down to 1mHz frequency. EIS
spectra were recorded as Bode plot.
Mott–Schottky plots
In principle, Mott–Schottky measurement is performed
by capacitance and potential (C/E) testing, which is
most suitable for semiconductor electrochemistry ana-
lysis. The Mott–Schottky was executed on the same
electrochemical work station and arrangements for
EIS, by scanning with DC potential (by potentiostate)
from 1.0V vs. SCE to 0.5 vs. SCE superimposed with
an alternating potential of 5mV at 1 kHz. Mott–
Schottky plots were recorded directly, and analyzed
by Mott–Schottky equation23
1
C2sc
¼
2
""0eND
E Efb 
kT
e
 
where Csc is the measured space-charge layer capaci-
tance; Efb represents flat-band postential; ND, the den-
sities of donors in space-charge layer; ", the relative
dielectric coefficient of titanium oxide film. Space
charge layer carrier concentration (NSC equivalent to
donor density ND) and Efb of the samples in PBS and
PBSþFbg were calculated by simulating the plot slope
(using the above Mott–Schottky equation).
Antithrombogenicity evaluation in vitro
The anti-thrombogenicity of the Ti-O films was evalu-
ated in terms of in vitro blood compatibility/hemocom-
patibility testing, namely, fibrinogen activation, relative
quantification of platelet adherent number, platelet
adhesion morphology observation, as well as clotting
time testing.
Fibrinogen denaturalization
Fibrinogen denaturalization on material surface is an
important stage of biomaterials-associated thrombosis,
which can be detected by an indirect immunochemistry
method with conformation-sensitive primary anti-
body.15–17 Specifically, platelet-poor plasma (PPP,
50 mL) was added on each sample surface and incubated
at 37C for 2 h. Then the samples were blocked by bovine
serum albumin (BSA) solution (1:100 diluted in PBS) for
30min and then incubated with mouse anti-human
fibrinogen g chain antibody (Accurate, Westbury, NY,
USA) (1/250 dilution in PBS) for 1 h. The samples were
washed with PBS and incubated with horseradish perox-
idase labelled goat anti-mouse antibody (Accurate,
Westbury,NY,USA) (1/100 dilution inPBS) for another
1 h, washed and colored with tetramethylbenzidine
(TMB) chromogen. Absorbance was read at 450 nm on
ELISA equipment by using microplate reader. The
fibrinogen denaturalization was related to the absorb-
ance and was calculated as percentage of activation by
calibrating with absorbance data of blank PPP (i.e. over
all fibrinogen in the 50 mL PPP as 100%), where n¼ 6 for
all samples measurements.
Lactate dehydrogenase activity measurement
of platelet adherent numbers
The amount of adherent platelets on the sample surface
was determined quantitatively by measuring the lactate
dehydrogenase (LDH) activity, namely the occurrence
of lysis on adhered platelets. The LDH samples mea-
sured 8mm 8mm with 4 numbers in each group.
Platelet-rich plasma (PRP, 50 mL) was dropped onto
each sample in the assay kit, and then incubated at
37C for 30min. After rinsing with phosphate-buffered
solution (PBS, 5min 3 times), Triton X-100 (diluted
to 1%, 40 mL) was added onto the surfaces of the sam-
ples to lyse the adherent platelets for 5min. Then lys-
ates (25 mL) was taken from the surfaces and mixed
with a substrate solution (b-Nicotinamide adenine
dinucleotide, reduced disodium salt, trihydrate
NADH, 200 mL) and sodium pyruvate in a 96-well
plate. The concentration of adhered platelet on samples
was colorimetrically measured as the optical density at
340 nm with a spectrometer (u-Quant, Bio-Tek
Instruments Inc.). The nominal concentration repre-
sents the percentage of adhered platelet number in the
total platelet number of 50 mL PRP.
Platelet adhesion testing and morphology observation
PRP was prepared by centrifuging (1500 r/min, 15min)
fresh human whole blood. The samples of 8mm 8mm
size were ultrasonically cleaned by acetone, ethanol and
distilled water and put in a silanized beaker. Then the
samples were immersed in PRP (50mL) and incubated
at 37C constant temperature for 30min. After being
washed with 0.9% NaCl solution, they were fixed
using 2.5% glutaraldehyde solution for 12 h, then
washed again with 0.9% NaCl three times, and subse-
quently immersed in 50%, 75%, 90% and 100% ethanol
solutions for 10min. After critical point drying
(CPD030, ALZERS Company), samples were processed
for observation by using field emission scanning electron
microscopy (SEM, JSM-7001F, JEOL Ltd., Japan).
Activated partial thromboplastin time
and thrombin time
The activated partial thromboplastin time (aPTT) and
thrombin time (TT) were measured on coagulometer
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(ACL 200, Instrumentation Laboratory Co. USA).
Fresh human PPP was prepared by centrifuging at
3000 r/min for 15min. For the aPTT measurement,
samples were attached to a 24-well culture plate.
Fresh human PPP (200 mL) and actin-activated
cephthaloplastin reagent (200mL) were added, followed
by the addition of 0.03M CaCl2 solution (200mL) after
incubation for 30min at 37C. The clotting time of the
plasma solution was measured by using the coagul-
ometer. In the case of the thrombin time (TT) measure-
ments, 200 mL incubated PPP was dropped onto the
surface of the samples. After incubation for 30min at
37C, the TT measurements were performed by adding
200 mL incubated PPP solution into 200 mL TT reagent
in a test tube, and then was measured by using the same
coagulometer.
Results
XPS spectra and XRD pattern
Surface chemical state of the prepared Ti-O films was
revealed by Ti 2 p XPS core level spectra as depicted in
Figure 1. The two overlapped band of Ti 2p1/2 and Ti
2p3/2 can be de-convoluted as Ti2þ, Ti3þ and Ti4þ
bonding states respectively, through curve-fitting by
Gaussian–Lorentzian peak model.24 The fitting results
of crystalline atom O/Ti ratio by Ti 2p XPS core level
spectra of the prepared Ti-O films are shown in Table 2.
Accordingly, with the decrease of oxygen partial pres-
sure during deposition, the Ti-O films were obtained
with reduced percentage of Ti4þ and relatively higher
percentage of Ti3þ and Ti2þ. The crystalline O/Ti ratio
of sample Ti-O #1, Ti-O #2 and Ti-O #3 decreased
from 1.56 to 1.49 and 1.43, suggesting that the Ti-O
films are all sub-stoichiometric titanium oxides.
Crystalline structure of the films is described by the
XRD patterns and identified as shown in Figure 2.25
Ti-O #1 sample was identified as mostly mixture exist-
ence of rutile (R) TiO2 and anatase (A) TiO2 phase
structure. Ti-O #2 showed two Ti2O3 peaks, mixed
mainly with R&ATiO2 peaks. Ti-O #3 sample appeared
to consist of more Ti2O3 and TiO phases. The change of
X-ray diffraction patterns of the prepared Ti-O samples
with decreasing of oxygen partial pressure indicates
that the structure of Ti-O films changed gradually
from mostly rutile and anatase TiO2 to Ti2O3 and
TiO with lower degree of crystallinity.
EIS spectra
Interfacial electrochemical behavior of titanium oxide
films in contact with fibrinogen containing phosphate
buffer saline can be well disclosed by their electrochem-
ical impedance spectra to reveal all the invloved
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Figure 1. Ti 2p X-ray photoelectron spectra of the prepared
Ti-O films (10 nm sputtering depth).
Table 2. The fitting results of crystalline O/Ti ratio by Ti 2p
X-ray photoelectron spectroscopy core level spectra and Ti
atom valence percentage of the prepared Ti-O films.
Samples
O/Ti
ratio
Valence percentage of Ti atom (%)
Ti2þ Ti3þ Ti4þ
Ti-O #1 1.56 31.1 26.3 42.6
Ti-O #2 1.49 35.4 31.0 33.6
Ti-O #3 1.43 42.5 29.0 28.5
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reactions, particularly including interfacial charge
transfer reaction resistance. Figure 3 shows EIS bode
spectra of the prepared Ti-O films in PBS and
PBSþFbg. Both in PBS and PBSþFbg, at highest
frequency of 105 Hz, impedance was attributed by solu-
tion resistance solely. At frequency range of 1000 to 1
Hz all Ti-O films appeared to have an increasing linear
impedance plot with decreasing of frequency. The
acompanying phase angles showed that there were
two time constant element (CE), which were overlapped
over the range. The first phase peak at around
1.05 102Hz is contributed to space charge layer cap-
acitance Csc and resistance of Ti-O film Rf; the second
at around 9.8 101 Hz is contributed to double layer
capacitance Cdl and interfacial reaction resistance Rct
(as the indicator of the degree of difficulty for charge
transfer from solution into Ti-O films). At 103Hz, the
impedance reached the highest and tend to be more
slightly increased, which is ascribed to the Wargburg
element of diffusion-controlled process. In PBS, the
Ti-O #1 seemed to have the highest interfacial reaction
resistance Rct, and Ti-O #2 and Ti-O #3 had similarly
lower Rct. Whereas in PBSþFbg, both Ti-O #1 and
Ti-O #3 showed obvious decreased Rct, Ti-O #2
showed ingnorable change (slighly increased) of Rct
when in contact with fibrinogen containing PBS as
compared to pure PBS. This revealed that Ti-O #2
has the highest interfacial reaction resistance to prevent
fibrinogen charge tranfer onto film surface.
Mott–Schottky plots
One of the important features of semiconductor elec-
trochemistry is the space charge layer built up on semi-
conductor surface when in contact with electrolyte,
owing to their separeted energy level and tendancy to
reach an equilibrium of accumulation of charge at the
interface. Mott–Schottky relation exists at the interface
and is employed to dictate the electronic structure
(positon of the energy band) of interface as well as
doping states (carriers density).23 Figure 4 depicts
experimental measure and linear fit of Mott–Schottky
plots of Ti-O samples in both PBS and PBSþFbg. All
the plots presented a positive slope around rest-open
potential of the samples, indicating that all the Ti-O
films are n-type semiconductor. Space charge layer car-
rier concentration Nsc and flat energy band potential
Efb of the three Ti-O films samples in PBS and
PBSþFbg were calculated and are listed in Table 3.
Ti-O #1 possessed apparently low Nsc and relatvely
positive Efb, indicating low degree of n-type doping.
In contrast, Ti-O #2 and Ti-O #3 both produced sig-
nificantly higher (about over 2 orders) Nsc value as well
as more negative Efb compared to Ti-O #1, indicating
that they were highly doped. Note Ti-O film 2# pre-
sented the most negative flat energy band potential
and highest carrier concentration even when in contact
with Fbg containing PBS, while Ti-O #3 showing an
extra linear section at more anodic scanned range can
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Figure 2. X-ray diffraction patterns of Ti-O films.
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be assigned to TiO phase contribution other than
TiO2 phase.
Fibrinogen denaturalization
The interfacial charge transfer facilitates conform-
ational change and hence chemical activation of
fibrinogen,20,26 which can be illustrated by fibrinogen
denaturalization results as plotted in Figure 5. Ti-O #2
film showed significantly least degree of Fbg activation,
whereas both Ti-O #1 and Ti-O #3 produced severe
degree of Fbg denaturalization, and the Ti-O #1
looked severest.
Lactate dehydrogenase assay
Higher levels of the surface adsorption and activation
of fibrinogen correlates with the adhesion and
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spectra of Ti-O samples in PBS and PBSþ Fbg (2mg/mL)
solutions.
PBS: phosphate buffered saline.
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aggregation of platelets on biomaterial surfaces.27
According to LDH results as shown in Figure 6, the
adhered platelet number on the Ti-O #2 sample are
significantly lower than Ti-O #1 and Ti-O #3, which
is consistent with Fbg denaturalization results.
Morphology observation of platelets adhesion testing
Morphology of platelet has been well-established as a
dictator of the extent of activation of platelets on for-
eign surfaces.28 Morphologies of adherent platelets on
Ti-O films by SEM observation are displayed in
Figure 7. Ti-O #2 appeared as natural round states
with less deformation; whereas serious pseudopodium
and aggregation occurred on Ti-O #3 and most severely
spreading activation were observed on Ti-O #1 surface.
Activated partial thromboplastin time
and thrombin time
Activated partial thromboplastin time (aPTT) provides
a simple and reliable measurement of the capacity of
blood to coagulate through intrinsic coagulation mech-
anism involving the effect of the biomaterial on delay of
the process. The activation on material surface takes
place via combined interactions among the coagulation
factors, for example, factor X activates and transforms
into factor Xa, factor Xa activates prothrombin (factor
II) to thrombin (factor IIa), and thrombin prompts
fibrinogen transform to fibrin, then the cascade of
coagulation proceeds until blood is clotted.29 The TT
test is used to evaluate the interval of activation of
fibrinogen to fibrin. All the three Ti-O films prolonged
aPTT and TT time (Figure 8) as compared to the orin-
ginal plasma, among them Ti-O #2 film showed signifi-
cantly higher value. The delayed clotting time results
were consistent with fibrinogen activation and platelets
adhesion results.
Discussion
The first major phenomenon when biomaterial is in
contact with blood is adsorption of plasma proteins
such as fibrinogen and albumin. The proteins involved
in coagulation might undergo conformational change
and further chemical activation.26 Then, platelet cells
are likely to interact with these proteins and the solid
surface to produce adhesion, aggragation and activa-
tion, finally triggering cascade reactions of throm-
bosis.27,30 Such process of thrombosis on material
surface is considered via silmilar pathology intrinsic
pathway of coagulation, involving a number of coagu-
lation factors with complicated interactions.2,3 It has
been shown that biomaterial-associated thrombosis is
accompanied with charge (electrons) transfer from the
inactive state of fibrinogen to the surface of the bioma-
terial,15–17 which causes fibrinogen to decompose
into monomers and peptides (denaturalization and acti-
vation). The resulting monomers then polymerize into
contrast Ti-O #1 Ti-O #2 Ti-O #3
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Table 3. Calculated carrier concentration Nsc and flat energy
band potential Efb of the films.
Sample
Efb (V vs. SCE) Nsc (cm
3)
In PBS In PBSþ Fbg In PBS In PBSþ Fbg
Ti-O #1 0.62 0.44 3.7E18 3.3E18
Ti-O #2 1.05 1.16 7.4E20 5.6E20
Ti-O #3 1.04 1.08 1.6E20 4.1E20
PBS: phosphate buffered saline.
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insoluble fibrin, and the cross-linked fibrins meshed
with platelets and red cells finally lead to an irreversible
thrombus. According to the electrochemical mechan-
ism, intuitively, the biomaterials that will inhibit
charge transfer from fibrinogen onto its surface could
perform good anti-thrombogenicity. This has been
proven reportedly on metals, i.e. active metals with
more cathodic electromotive force, like magnesium,
are more anti-thrombogenic due to higher Fermi
levels as compared to noble metals in the anodic side
of electromotive series.31 Nevertheless, based on metal
electrochemistry theory, both cathodic and anodic dir-
ection of charge transfer at the metal/electrolyte inter-
face are always inevitable as the metals’ Fermi levels are
readily adjusted to electrochemical energy level of solu-
tion (electrolyte), i.e. fibrinogen activation always
occurs inevitably in such case. This might be the
reason why metals possess unsatisfying anti-
thrombgenicity.31,32
In contrast to metals, semiconductor electrode pro-
vides independent surface energy level (for example, the
bottom of conduction band Esc and the top of valence
band Esv) with regard to electrochemical energy level of
electrolyte (fibrinogen herein).23,33 As illustrated in
Figure 9, according to semiconductor electrochemis-
try,33 the difference in energy level on two sides of
solid/solution interface is actually fixed, and determines
the charge transfer direction thermodynamically and
the reaction resistance kinetically. For n-type wide-
gap semiconductor titanium oxide (3.0–3.2 eV), the
high level of doping gives rise to higher carrier density
(or electrons donor) in space charge layer, which pre-
vent electron transfer from fibrinogen; in addition,
more negative flat-band potential relates to higher pos-
ition at the bottom of conduction band Esc energy level,
then higher energy barrier T is thus built up between
fibrinogen and semiconductor, therefore giving rise to
larger resistance to charge transfer from fibrinogen to
Ti-O films.
Our prepared Ti-O films are all substoichiometric,
and the O deficiency are likely to produce Ti 3d orbital
energy levels n-type doping, similar to oxygen vacancy
n-doping mechanism in TiO2.
25 Ti-O #1 consists
of more stoichiometric TiO2 crystalline phase, and
provide apparently low carrier concentration in
space charge layer as well as relatively more postive
flat-band potential (lower position of conduction
Figure 7. Representative scanning electron microscopic
photos of adherent platelet morphology on Ti-O films with
platelet-rich plasma for 30min.
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Figure 8. Activated partial thromboplastin time (aPTT)
and thrombin time (TT) results of Ti-O films (n¼ 6) with
platelet-poor plasma.
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726 Journal of Biomaterials Applications 28(5)
band bottom). Ti-O #2 and Ti-O #3 have obviously
higher degree of doping with lower O/Ti ratio, leading
to increased surface carrier concentration and higher
Fermi levels,33 and the electrons tend to escape from
the Ti-O film, i.e. the charge transfer from fibrinogen to
Ti-O film is inhibited more efficiently. Nevertheless,
Ti-O #3 possess more Ti2O3 and particularly TiO
phase which provide a lower degree of doping in
whole film as well as an extra lower conduction band
position beyond that of TiO2 phase,
34 which can be
ascertained by Mott–Shottky plot, where there appears
an extra linear section at more anodic scanning range.
This could reduce the energy position barrier and prob-
ably allow more charge transfer from fibrinogen to
Ti-O films.35 In short, the anti-thrombogenicity of
titanium oxide films seems dependent upon the
unique semiconducting property. The n-type character-
istic with space charge layer of high density donor
states and higher position of surface energy level (Esc)
plays a decisive role in establishment of an electrochem-
ical interfacial energy barrier. Such barrier will largely
reduce the risk of fibrinogen activation by preventing
its electrons charge transfer toward Ti-O films, which
subsequently results in less possibility of platelets acti-
vation and finally good anti-thrombogenicity.35
The electrochemical behavior of the real semicon-
ductor–blood interface might not only be used to
better understand the biomaterials-associated throm-
bosis,36,37 but possibly also provide an important cri-
terion to screen or optimize anti-thrombogenic
semiconducting biomaterials like Ti-O films and
others.38–40
Conclusion
In this article, we prepared sub-stoichiometric Ti-O
films of three O/Ti ratios. All the Ti-O films are
n-type semiconductor, but offered different degrees of
doping as well as surface energy level position. We
found that the anti-thrombogenicity of Ti-O films cor-
related directly with their interfacial electrochemical
behaviors in fibrinogen containing phosphate buffer
solution, and is sensitively related to their stoichiomet-
ric O/Ti ratio and crystalline phase structure. A ration-
ale of energetics of the semiconductor Ti-O film/
fibrinogen interface was discussed, and is proposed to
guide further improvement in antithrombogenicity of
semiconducting biomaterials. A sufficient energy bar-
rier between the fibrinogen in blood and the biomater-
ials will be needed to inhibit fibrinogen activation by
preventing charge transfer onto the biomaterials sur-
face, eventually lessening the likelihood of triggering
the cascade blood coagulation reactions, and therefore
finally avoiding thrombosis. More specifically for titan-
ium oxide films, those with higher degree of inherent n-
type doping would best prevent the charge transfer
from fibrinogen (namely its activation), and hence
potentially serve best for surface-modification of
blood-contacting implantable devices such as cardio-
vascular stents and artificial heart valves. The future
work might focus more on effective ways to impede
the charge transfer, as well as taking systematic consid-
erations thereof in the whole picture of real interfacial
electrochemical interactions between blood and the
semiconducting biomaterials.
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